Can you develop a tolerance to allergy medication? It is a question many hay fever and allergy sufferers ask, particularly when their antihistamine seems less effective than it once did. Understanding how allergy medications work — and whether the body genuinely adapts to them over time — is essential for managing symptoms safely and effectively. This article explores the evidence behind antihistamine tolerance, what NHS and NICE guidance says about long-term use, how to recognise when your medication may need reviewing, and when to seek advice from a pharmacist, GP, or specialist allergy service.

How Allergy Medications Work in the Body

Allergy medications work by targeting specific components of the immune response that cause symptoms such as sneezing, itching, a runny nose, and watery eyes. The most commonly used class of allergy medication is antihistamines, which block histamine H1 receptors. When the body encounters an allergen — such as pollen, pet dander, or dust mites — mast cells release histamine, which binds to these receptors and triggers the familiar cascade of allergic symptoms. By occupying the receptor sites, antihistamines prevent histamine from binding and reduce the severity of the reaction.

There are two main generations of oral antihistamines available in the UK. First-generation antihistamines (such as chlorphenamine) cross the blood-brain barrier and can cause sedation, dry mouth, and blurred vision. They are not recommended for routine long-term use, particularly in older adults, drivers, or those operating machinery. Second-generation antihistamines (such as cetirizine and loratadine) are less sedating and are generally preferred for long-term use, as supported by NICE CKS guidance on allergic rhinitis. Cetirizine and loratadine are available over the counter as general sale or pharmacy medicines; fexofenadine 120 mg is available as a pharmacy-only medicine, while higher-strength formulations require a prescription. Always follow the dosing instructions in the patient information leaflet or as directed by a pharmacist or GP, and do not exceed the recommended dose.

Other allergy medications include:

• Intranasal corticosteroids (e.g., beclometasone, fluticasone) — which reduce nasal inflammation by suppressing local immune activity and are considered first-line treatment for moderate-to-severe allergic rhinitis by NICE

• Intranasal antihistamines (e.g., azelastine) and combination intranasal sprays (e.g., azelastine with fluticasone) — prescription options that can provide faster symptom relief for nasal symptoms

• Leukotriene receptor antagonists (e.g., montelukast) — prescription-only medicines that block inflammatory mediators; montelukast is not first-line for allergic rhinitis without co-existing asthma, and the MHRA has issued a Drug Safety Update highlighting the risk of neuropsychiatric reactions (including sleep disturbances, anxiety, and mood changes); patients and carers should be counselled about these risks before starting treatment

• Mast cell stabilisers (e.g., sodium cromoglicate) — which prevent mast cells from releasing histamine

Understanding how each medication works is important when considering whether the body can adapt to their effects over time, which is a question many people with seasonal or perennial allergies reasonably ask.

If you think you are experiencing a side effect from any allergy medication, you can report it via the MHRA Yellow Card Scheme at yellowcard.mhra.gov.uk.

What Tolerance Means and Whether It Applies to Antihistamines

Pharmacological tolerance occurs when the body adapts to a drug over time, requiring higher doses to achieve the same effect. This is well-documented with substances such as opioids and benzodiazepines, where receptor downregulation or changes in drug metabolism reduce the drug's effectiveness. However, the situation with antihistamines is more nuanced and is often misunderstood.

For second-generation antihistamines, there is no robust clinical evidence to suggest that true pharmacological tolerance develops with regular use. Studies have not demonstrated significant H1 receptor downregulation in response to long-term antihistamine use, and NICE CKS guidance supports their continued use for persistent allergic rhinitis without recommending rotation to prevent tolerance.

That said, some people do report that their antihistamine seems less effective after taking it for a prolonged period. This is more likely explained by:

• Worsening of the underlying allergy — allergen exposure can increase over time, particularly with perennial allergens

• Changes in the allergen environment — for example, higher pollen counts in a given season

• Suboptimal timing or dosing — antihistamines are often more effective when taken before allergen exposure rather than after symptoms begin

• New sensitisation — some people develop reactivity to additional allergens over time

It is important to distinguish antihistamines from topical nasal decongestants (e.g., xylometazoline), which can cause rebound nasal congestion (rhinitis medicamentosa) if used for more than five to seven days. This rebound effect is sometimes mistaken for tolerance to allergy medication more broadly, but it is a separate phenomenon specific to topical decongestants. Topical nasal decongestants should not be used for more than a few days at a time.

If your medication appears less effective, it is important to explore all possible explanations before assuming tolerance has developed.

Signs Your Allergy Medication May Be Less Effective

Recognising when your allergy medication is no longer providing adequate symptom control is an important part of managing your condition safely. Symptoms that were previously well-controlled returning with greater intensity may suggest that your current treatment approach needs reviewing — though this does not necessarily mean tolerance has developed.

Common signs that your allergy medication may be less effective include:

• Breakthrough symptoms despite taking medication consistently and at the correct dose

• Increased frequency of symptoms, such as sneezing or itching, even outside of peak allergen seasons

• Worsening sleep quality due to nasal congestion or other allergic symptoms

• Reduced response to the same dose that previously provided good relief

• New symptoms that were not previously part of your allergic profile, such as developing asthma symptoms alongside hay fever

Seek emergency help immediately (call 999) if you experience signs of anaphylaxis or a severe allergic reaction, including lip, tongue, or throat swelling, difficulty breathing, severe wheeze, chest tightness, or feeling faint. These are medical emergencies and require urgent treatment.

It is also worth considering whether lifestyle or environmental factors have changed. Moving to a new area, acquiring a pet, or changes in workplace environment can all increase allergen exposure significantly. Additionally, some people develop new sensitivities to allergens they were not previously reactive to — this can occur at any age and is separate from the concept of the allergic march, which specifically describes the typical progression of atopic conditions (eczema, food allergy, asthma, and rhinitis) in childhood.

If you are taking an over-the-counter antihistamine and finding it less effective, it may be worth reviewing whether you are taking it at the optimal time of day and whether the dose is appropriate for your age, as per the patient information leaflet or SmPC. Do not exceed the recommended dose, and do not take more than one oral antihistamine at the same time without medical advice. A pharmacist can offer helpful initial guidance without the need for a GP appointment.

What NHS and NICE Guidelines Say About Long-Term Use

NICE CKS guidance on allergic rhinitis supports the long-term use of second-generation antihistamines and intranasal corticosteroids as safe and effective options for managing persistent allergic symptoms. There is no NICE recommendation advising patients to rotate antihistamines to prevent tolerance, as the evidence base does not support this practice for second-generation agents.

For seasonal allergic rhinitis (hay fever), NICE recommends starting treatment before the pollen season begins and continuing throughout the season. For perennial allergic rhinitis, long-term daily use of a non-sedating antihistamine or intranasal corticosteroid is considered appropriate and safe. Intranasal corticosteroids are generally considered more effective than oral antihistamines alone for nasal symptoms and are the preferred first-line treatment for moderate-to-severe rhinitis according to NICE CKS.

The NHS advises that most second-generation antihistamines are safe for long-term use. However, first-generation (sedating) antihistamines should not be used routinely on a long-term basis. The MHRA has highlighted the risks of sedating antihistamines in older adults, including increased risk of falls, cognitive impairment, and anticholinergic side effects. They should also be avoided by people who drive or operate machinery, as they can impair reaction times even when sedation is not obvious.

For patients whose symptoms are not adequately controlled with standard treatments, NICE supports referral to a specialist allergy service for consideration of allergen immunotherapy (desensitisation). NICE Technology Appraisals have approved sublingual immunotherapy for grass pollen allergy (e.g., Grazax) and house dust mite allergy (e.g., Acarizax) for selected patients; subcutaneous immunotherapy (SCIT) is also available via specialist services. Immunotherapy is the only treatment that modifies the underlying allergic response rather than simply managing symptoms, and it must be initiated and supervised by a specialist. It is not suitable for patients with uncontrolled asthma.

When to Switch Medications or Seek Medical Advice

Call 999 or go to your nearest A&E immediately if you experience signs of anaphylaxis or a severe allergic reaction — including swelling of the lips, tongue, or throat, difficulty breathing, severe wheeze, chest tightness, or collapse. These are medical emergencies.

If your current allergy medication is no longer providing adequate symptom control for milder symptoms, there are several steps you can take. A pharmacist can review your current regimen and suggest an alternative antihistamine or recommend adding an intranasal corticosteroid spray, many of which are now available over the counter. Switching between second-generation antihistamines — for example, from cetirizine to loratadine — is a reasonable approach if one agent appears less effective, as individual responses can vary. Do not take more than one oral antihistamine at the same time without advice from a pharmacist or GP.

You should contact your GP if:

• Your symptoms are significantly affecting your quality of life, sleep, or ability to work or study

• Over-the-counter treatments have failed to provide adequate relief after a reasonable trial period

• You develop new or worsening symptoms, such as facial pain or pressure (suggesting sinusitis), shortness of breath, or a persistent cough

• You experience side effects from your current medication — these can also be reported via the MHRA Yellow Card Scheme at yellowcard.mhra.gov.uk

• You are pregnant, breastfeeding, or managing other medical conditions that may affect which medications are safe for you

• You suspect your allergy has changed or you have developed a new allergy

Your GP may consider prescription options before referral, including intranasal antihistamines (e.g., azelastine) or a combination intranasal azelastine/fluticasone spray, which can be effective when over-the-counter treatments are insufficient. In some cases, your GP may refer you to an NHS allergy clinic for skin prick testing or specific IgE blood tests to identify your allergens more precisely. This can help tailor your management plan and determine whether immunotherapy might be appropriate.

Managing Allergies Safely Over Time

Long-term allergy management is most effective when it combines appropriate medication with practical strategies to reduce allergen exposure. For hay fever sufferers, this might include checking daily pollen forecasts, keeping windows closed during high pollen periods, showering after spending time outdoors, and wearing wraparound sunglasses. For those with perennial allergies to house dust mites, using allergen-proof mattress and pillow covers, washing bedding at 60°C, and reducing soft furnishings can make a meaningful difference.

It is important to use medications correctly and consistently. Intranasal corticosteroid sprays take several days to reach their full effect (and up to two weeks for maximum benefit) and should be used regularly rather than on an as-needed basis. When using a nasal spray, aim the nozzle towards the outer wall of the nostril rather than towards the nasal septum, to reduce the risk of nosebleeds and improve efficacy. The NHS provides guidance on correct nasal spray technique. Antihistamines are generally more effective when taken before allergen exposure — for instance, before going outdoors during pollen season — rather than waiting until symptoms are already established.

If you use a topical nasal decongestant spray for congestion, limit use to no more than five to seven days to avoid rebound congestion. These products are not a substitute for antihistamines or intranasal corticosteroids for ongoing allergy management.

For patients with more complex or severe allergies, allergen immunotherapy — available as subcutaneous injections (SCIT) or sublingual tablets or drops (SLIT) — offers the possibility of long-term disease modification. NICE-approved sublingual immunotherapy for grass pollen allergy (Grazax) and house dust mite allergy (Acarizax) is available on the NHS in some areas for patients who meet the criteria set out in NICE Technology Appraisals. Immunotherapy must be initiated and supervised by a specialist allergy service and is not suitable for patients with uncontrolled asthma.

Finally, keeping a symptom diary to track patterns, identify triggers, and monitor the effectiveness of your treatment is invaluable when discussing your care with a GP or allergy specialist. If you suspect any medication is causing a side effect, report it via the MHRA Yellow Card Scheme at yellowcard.mhra.gov.uk. Managing allergies is an ongoing process, and with the right combination of medication, environmental control, and professional support, most people can achieve good symptom control and maintain their quality of life safely over the long term.

Frequently Asked Questions